that's becuase it has risen in line with the rising UWL price ... UWL doesn't have to chase. they own 20% of OPC and have the equivalent of a $6 offer for the rest
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling